Aminov Erez 4
4 · Telomir Pharmaceuticals, Inc. · Filed May 30, 2025
Insider Transaction Report
Form 4
Aminov Erez
DirectorCEO and Chairman
Transactions
- Award
Non-Qualified Options
2025-05-28+2,000,000→ 2,000,000 totalExercise: $2.10Exp: 2035-05-28→ Common Stock (2,000,000 underlying) - Award
Restricted Stock Units (RSUs)
2025-05-28+400,000→ 400,000 total→ Common Stock (400,000 underlying)
Footnotes (5)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 27, 2025.
- [F2]The stock options were issued to the Reporting Person on May 28, 2025, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). The stock options are fully vested as of the date of grant.
- [F3]Each restricted stock unit represents a right to receive one share of Issuer's common stock.
- [F4]The RSUs were issued to the Reporting Person on May 28, 2025, pursuant to a grant under the Plan. The RSUs are fully vested as of the date of grant.
- [F5]Each restricted stock unit represents a right to receive one share of Issuer's common stock.